Pharma News By Region

Agilent Technologies Inc. has received a 2017 Scientists' Choice Award for Best New Clinical Laboratory Product: the IQFISH Panel for Lung Cancer. The IQFISH panel for lung cancer makes it easier for pathology labs to integrate fast, high-quality FISH (fluorescent in situ hybridization) into their IHC workflows. The announcement was…
InDex Pharmaceuticals Holding AB (publ) today announced that a new method of use patent for the drug candidate cobitolimod has been granted by the Japan Patent Office. The patent provides additional protection for the use of certain dosage regimens of cobitolimod for treating chronic active ulcerative colitis in patients that…
Daiichi Sankyo Company has announced that DS-8201, an investigational HER2-targeting antibody drug conjugate (ADC), demonstrated preliminary anti-tumour activity in patients with HER2-expressing solid tumours such as colon cancer, non-small cell lung cancer and other tumour types. These data were presented during a poster session at the European Society for Medical…
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, today announced that the United States Food and Drug Administration (“FDA”) has granted orphan designation to omaveloxolone for the treatment of Stage IIb through IV malignant melanoma.   Reata is currently executing a Phase 1b/2 trial evaluating the safety and efficacy of omaveloxolone…
Sanofi announced that the U.S. FDA granted tentative approval for Admelog® (insulin lispro injection) 100 Units/mL, a rapid-acting human insulin analog. Admelog is indicated to improve glycemic control in adults and children with diabetes mellitus. The tentative approval is based on physicochemical, non-clinical and clinical similarity to another insulin lispro…
Page 1 of 63

Subscribe To Our Newsletter

Security Q:How many eyes has a typical person? (ex: 1)
Name:
Email: